Bradlow RCJ, Berk M, Kalivas PW, Back SE, Kanaan RA
It is said to be very powerful in various applications
Whether raising IGF-1 with a secretagogue produces the outcomes people actually care about changes in body composition, physical function, recovery, healthspan is a separate question that requires long-term outcome trials GHRP-2 does not have
This neuroprotective mechanism was found to occur in concert with a suppression of proinflammatory cytokines released from the activated microglia, suggesting an anti-inflammatory mechanism upstream from the neurodegeneration of dopaminergic neurons
However, it is important to note glycosylation patterns and glycan species can vary in different cell types 15 and are altered in malignant cells compared to non-malignant cells 16
FDA has evaluated glutathione for potential compounding but has not approved it as a finished drug product